Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 5
2005 5
2006 4
2007 5
2008 11
2009 18
2010 21
2011 12
2012 9
2013 7
2014 8
2015 5
2016 10
2017 11
2018 14
2019 14
2020 18
Text availability
Article attribute
Article type
Publication date

Search Results

154 results
Results by year
Filters applied: . Clear all
Page 1
Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial.
Kahl S, Gancheva S, Straßburger K, Herder C, Machann J, Katsuyama H, Kabisch S, Henkel E, Kopf S, Lagerpusch M, Kantartzis K, Kupriyanova Y, Markgraf D, van Gemert T, Knebel B, Wolkersdorfer MF, Kuss O, Hwang JH, Bornstein SR, Kasperk C, Stefan N, Pfeiffer A, Birkenfeld AL, Roden M. Kahl S, et al. Among authors: machann j. Diabetes Care. 2020 Feb;43(2):298-305. doi: 10.2337/dc19-0641. Epub 2019 Sep 20. Diabetes Care. 2020. PMID: 31540903 Clinical Trial.
Genome-Wide and Abdominal MRI Data Provide Evidence That a Genetically Determined Favorable Adiposity Phenotype Is Characterized by Lower Ectopic Liver Fat and Lower Risk of Type 2 Diabetes, Heart Disease, and Hypertension.
Ji Y, Yiorkas AM, Frau F, Mook-Kanamori D, Staiger H, Thomas EL, Atabaki-Pasdar N, Campbell A, Tyrrell J, Jones SE, Beaumont RN, Wood AR, Tuke MA, Ruth KS, Mahajan A, Murray A, Freathy RM, Weedon MN, Hattersley AT, Hayward C, Machann J, Häring HU, Franks P, de Mutsert R, Pearson E, Stefan N, Frayling TM, Allebrandt KV, Bell JD, Blakemore AI, Yaghootkar H. Ji Y, et al. Among authors: machann j. Diabetes. 2019 Jan;68(1):207-219. doi: 10.2337/db18-0708. Epub 2018 Oct 23. Diabetes. 2019. PMID: 30352878 Free article.
Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
Markova M, Pivovarova O, Hornemann S, Sucher S, Frahnow T, Wegner K, Machann J, Petzke KJ, Hierholzer J, Lichtinghagen R, Herder C, Carstensen-Kirberg M, Roden M, Rudovich N, Klaus S, Thomann R, Schneeweiss R, Rohn S, Pfeiffer AF. Markova M, et al. Among authors: machann j. Gastroenterology. 2017 Feb;152(3):571-585.e8. doi: 10.1053/j.gastro.2016.10.007. Epub 2016 Oct 17. Gastroenterology. 2017. PMID: 27765690 Clinical Trial.
Potential effects of reduced red meat compared with increased fiber intake on glucose metabolism and liver fat content: a randomized and controlled dietary intervention study.
Willmann C, Heni M, Linder K, Wagner R, Stefan N, Machann J, Schulze MB, Joost HG, Häring HU, Fritsche A. Willmann C, et al. Among authors: machann j. Am J Clin Nutr. 2019 Feb 1;109(2):288-296. doi: 10.1093/ajcn/nqy307. Am J Clin Nutr. 2019. PMID: 30721948 Clinical Trial.
Metabolomic Characteristics of Fatty Pancreas.
Jaghutriz BA, Wagner R, Heni M, Lehmann R, Machann J, Stefan N, Häring HU, Fritsche A. Jaghutriz BA, et al. Among authors: machann j. Exp Clin Endocrinol Diabetes. 2019 May 16. doi: 10.1055/a-0896-8671. Online ahead of print. Exp Clin Endocrinol Diabetes. 2019. PMID: 31096268
Choline Supplementation in Cystic Fibrosis-The Metabolic and Clinical Impact.
Bernhard W, Lange R, Graepler-Mainka U, Engel C, Machann J, Hund V, Shunova A, Hector A, Riethmüller J. Bernhard W, et al. Among authors: machann j. Nutrients. 2019 Mar 18;11(3):656. doi: 10.3390/nu11030656. Nutrients. 2019. PMID: 30889905 Free PMC article.
Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial.
Kantartzis K, Fritsche L, Bombrich M, Machann J, Schick F, Staiger H, Kunz I, Schoop R, Lehn-Stefan A, Heni M, Peter A, Fritsche A, Häring HU, Stefan N. Kantartzis K, et al. Among authors: machann j. Diabetes Obes Metab. 2018 Jul;20(7):1793-1797. doi: 10.1111/dom.13268. Epub 2018 Mar 22. Diabetes Obes Metab. 2018. PMID: 29484808 Clinical Trial.
Acute Endothelial Benefits of Fat Restriction over Carbohydrate Restriction in Type 2 Diabetes Mellitus: Beyond Carbs and Fats.
Barbosa-Yañez RL, Dambeck U, Li L, Machann J, Kabisch S, Pfeiffer AFH. Barbosa-Yañez RL, et al. Among authors: machann j. Nutrients. 2018 Dec 1;10(12):1859. doi: 10.3390/nu10121859. Nutrients. 2018. PMID: 30513768 Free PMC article. Clinical Trial.
Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion.
Gerst F, Wagner R, Kaiser G, Panse M, Heni M, Machann J, Bongers MN, Sartorius T, Sipos B, Fend F, Thiel C, Nadalin S, Königsrainer A, Stefan N, Fritsche A, Häring HU, Ullrich S, Siegel-Axel D. Gerst F, et al. Among authors: machann j. Diabetologia. 2017 Nov;60(11):2240-2251. doi: 10.1007/s00125-017-4385-1. Epub 2017 Aug 8. Diabetologia. 2017. PMID: 28791439
Magnetic resonance imaging of obesity and metabolic disorders: Summary from the 2019 ISMRM Workshop.
Hu HH, Branca RT, Hernando D, Karampinos DC, Machann J, McKenzie CA, Wu HH, Yokoo T, Velan SS. Hu HH, et al. Among authors: machann j. Magn Reson Med. 2020 May;83(5):1565-1576. doi: 10.1002/mrm.28103. Epub 2019 Nov 29. Magn Reson Med. 2020. PMID: 31782551
154 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback